Reducing Adult Inpatients Anxiety With Virtual Reality Meditation

Not Applicable

Not yet recruiting

• Conditions: Anxiety; Virtual Reality
• Interventions: Behavioral: Virtual Reality headset with calming scenery

• Registration Number: NCT06234254
• Lead Sponsor: Stanford University

Brief Summary

The purpose of the study is to evaluate if non-invasive, distracting devices (virtual reality) can decrease anxiety and improve affect and satisfaction in adult, hospitalized patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-01-22
• Study First Submitted QC: 2024-01-22
• Study First Posted: 2024-01-31
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-15
• Last Update Posted: 2025-05-16
• Study Start: 2026-06-01
• Primary Completion: 2027-05-31
• Study Completion: 2027-05-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• between age 18-99
• hospitalized at Stanford Health Care
• english-speaking

Exclusion Criteria

• significant cognitive impairment or inability to consent
• current nausea
• visual problems or currently using corrective glasses that are incompatible with the virtual reality headset
• a history of severe motion sickness
• a history of seizures cause by flashing light
• clinically unstable or require immediate/urgent intervention

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Virtual Reality	Virtual Reality headset with calming scenery	Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes

Primary Outcome Measures

Name	Time	Method
Hospital Anxiety and Depression Scale (HADS)	Before and Immediate after intervention	Hospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.

Trial Locations

Locations (1)

Stanford Health Care (SHC); 🇺🇸 Palo Alto, California, United States